ArticleWorld journal of oncology2025

Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients.

Shereef Ahmed Elsamany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.